GLPwatch
The impact of preadmission/prediagnosis use of GLP-1 receptor agonists on COVID-19 mortality in patients with diabetes: A systematic review and meta-analysis.
Health Sci Rep · 2023
Last updated 2026-05-28| Journal | Health Sci Rep, 2023 |
|---|---|
| Citations | 2 |
| Relative citation ratio | 0.23 |
| NIH percentile | 15 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 37720167 ↗